Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA salermide CTRPv2 pan-cancer AAC 0.025 0.6
mRNA PI-103 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA nintedanib CTRPv2 pan-cancer AAC -0.019 0.6
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.019 0.6
mRNA austocystin d CTRPv2 pan-cancer AAC -0.018 0.6
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC -0.018 0.6
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.019 0.7
Download CSV